NFKB1 and familial pancreatic carcinoma: Recently, SIRT6 has been demonstrated to inhibit nuclear transcription of NF-κB and inactivate NF-κB to facilitate ferroptosis in pancreatic cancer, thereby exerting anti-tumor effects (Gong et al., 2022).